SCHEMBL22955472

SCHEMBL22955472

CC(C)(C)c1ccc2ncc(C(N)=O)nc2c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 2/20 0.49
▸ LRRK2 Q5S007 1/20 0.46
▸ SCN10A Q9Y5Y9 6/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ GRM2 Q14416 1/20 0.38
▸ IKBKB O14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30310860 0.79 KMT2A (0.55) TGFBR1KMT2AALDH1A1HPGDALOX15
SCHEMBL24506571 0.76 TGFBR1 (0.38) TGFBR1LRRK2SCN10AKMT2ATRPV1
SCHEMBL22280319 0.76 TGFBR1 (0.49) TGFBR1SCN10AKMT2AALDH1A1HPGD
SCHEMBL26351997 0.76 HPGDS (0.50) LRRK2SCN10ATRPV1IKBKB
SCHEMBL23335990 0.74 KMT2A (0.44) KMT2AALDH1A1HPGDALOX15HSD17B10
SCHEMBL7448063 0.74 TGFBR1 (0.47) TGFBR1ALDH1A1HPGDALOX15HSD17B10
SCHEMBL11922120 0.74 PDE10A (0.41) SCN10AKMT2ATRPV1ALDH1A1HPGD
SCHEMBL20043209 0.74 PDE10A (0.41) LRRK2SCN10ATRPV1ALDH1A1HPGD
SCHEMBL851358 0.73 ALDH1A1 (0.69) TGFBR1ALDH1A1HPGDALOX15HSD17B10
SCHEMBL29540343 0.73 ALDH1A1 (0.69) TGFBR1ALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11466003-B2 Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2022-10-11 — — US disclosed
US-20210032242-A1 AROMATIC HETEROCYCLIC SUBSTITUTED OLEFIN COMPOUND, PREPARATION METHOD FOR SAME, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2021-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210032242-A1 AROMATIC HETEROCYCLIC SUBSTITUTED OLEFIN COMPOUND, PREPARATION METHOD FOR SAME, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF ALK, ALKBH5, ALKBH3 TGFBR1 599/4885LRRK2 1580/4885SCN10A 3237/4885
US-11466003-B2 Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof NOTUM, ALKBH5, PAH TGFBR1 613/4885LRRK2 1861/4885SCN10A 2226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback